Triluma Hydroquinone USP 4.00% W/W + Tretinoin USP 0.05% W/W + Fluocinolone Acetonide IP 0.01% W/W Topical Cream

Triluma® Cream is a prescription topical treatment formulated with Hydroquinone 4%, Tretinoin 0.05%, and Fluocinolone Acetonide 0.01% to help manage moderate to severe melasma on the face. This triple-combination formula works by reducing excess melanin production, promoting skin cell turnover, and calming inflammation to improve the appearance of dark patches and uneven skin tone.

When used as directed by a healthcare professional, Triluma Cream helps fade stubborn pigmentation, improve skin clarity, and promote a brighter, more even-looking complexion. It is typically prescribed as part of a comprehensive skincare regimen that includes strict sun protection.

• Triple-action formula with Hydroquinone 4%, Tretinoin 0.05%, and Fluocinolone Acetonide 0.01%
• Helps treat moderate to severe facial melasma
• Reduces the appearance of dark patches and hyperpigmentation
• Promotes skin cell renewal for a smoother, more even complexion
• Helps calm skin inflammation associated with pigmentation disorders
• Prescription-strength topical cream

Apply a thin layer to the affected areas once daily in the evening or exactly as prescribed by your healthcare provider. Wash your hands before and after application, and avoid contact with the eyes, lips, nostrils, and broken skin. Use a broad-spectrum sunscreen with SPF 30 or higher and minimise sun exposure during treatment to help maintain results.